Schedule 13G ownership disclosure

APREA THERAPEUTICS INC

Common stock, par value $0.001 per share · CUSIP: 03836J201

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 411,520.00 · Class: 4.50%

  • Wilmot B. Harkey

    Shares: 411,520.00 · Class: 4.50%

  • Daniel Mack

    Shares: 411,520.00 · Class: 4.50%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-015324
Form type
SCHEDULE 13G/A
Filer
Aprea Therapeutics, Inc.
CIK
CIK 1781983
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub